The connection between human health and the environment we live in has been appreciated by all cultures throughout human history. The physical manifestation of this connection has been dramatically demonstrated by the toll on human life caused by volcanic eruptions, earthquakes, hurricanes, landslides, tsunamis, and other natural disasters, and these effects may be considered under the term "geology and human health." Among the best-known examples are the Vesuvian eruptions of 79 AD that buried Pompeii and Herculaneum in Italy and the tsunamis represented in the beautiful nineteenth century Japanese woodblock prints by Katsushika Hokusai.
Chemical links between the environment and human health, however, tend to be more difficult to identify and understand in terms of the biogeochemical mechanisms by which they affect human health. Lead (plumbum in Latin) in drinking-water pipes (hence "plumbing") and in pewter wine goblets has been identified only in recent times as the source of widespread poisoning in ancient Rome. The importance of such links is captured in classic textbooks on bioinorganic chemistry (Fraústo da Silva and Williams 1991; Williams and Fraústo da Silva 1996) . The field of "medical mineralogy and geochemistry" (MMG) focuses on understanding the equilibria and reaction pathways involving normal and pathological interactions of inorganic and organic chemical species in gas or aqueous phases with naturally occurring, inorganic solid phases within the human body.
Medical mineralogy and geochemistry as broadly described here overlaps considerably with other areas of research, such as bioinorganic chemistry, biochemistry, epidemiology, etiology (cause of disease), biomineralization, and biomaterials (FIG. 1) . The field also has connections to the huge biological research areas of genetics, molecular biology, and cell biology. The overlap is intentional and necessary, but many of these other research areas focus on the organic and biological aspects of human health, with minimal appreciation for the richness and complexity of the contributions of inorganic solid phases in these processes. Seemingly trivial examples are provided by the terms "silicosis" and "calcification" of bones and arteries, which are widely used in the medical literature but do not specify the mineral actually involved. These processes might more appropriately be called "quartzicosis" and "phosphatization" (Glimcher 2006) . Thus, I distinguish MMG from the related research fields by the former's emphasis on the critical role played in the human body by "naturally occurring inorganic solid phases," that is, by minerals, amorphous solids, nanocrystals, and nanoclusters. For brevity, and with apologies to mineralogists, in the subsequent discussion the term "mineral" will include true minerals and biominerals (which are composite materials) as well as inorganic amorphous solids, nanoparticles, and nanoclusters.
The range of issues includes the medical condition involving the specific mineral, the affected tissue or organ, the etiology of the condition, exposure pathways, geospatial issues, pathogenesis, controlling equilibria and reaction mechanisms, and the cure (FIG. 2) . In order to solve the pathological case, it is often necessary to understand the normal process. For instance, understanding osteoporosis and normal bone mineralization go hand in hand. MMG, in other words, deals not only with medical "problems" but also with normal physiological processes involving minerals and inorganic or organic species in the fluid phase. M edical mineralogy and geochemistry is a highly interdisciplinary area of research where the complexity of minerals and mineral surface reactivity in the human body is emphasized. Research in this field will lead to an understanding of the biogeochemical processes responsible for specific medical conditions, both normal and pathological, that involve the interaction of dissolved inorganic species and bioorganic molecules with minerals. In this article, I highlight some fundamental concepts and challenges in this endeavor, and the subsequent articles provide overviews of specific topics.
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Schematic diagram to illustrate overlap between medical mineralogy and geochemistry (MMG) and other related fields.
FIGURE 1
A partial list of MMG research topics is provided by the recent volume 64 of the Reviews in Mineralogy & Geochemistry series (Sahai and Schoonen 2006) and by the articles in this issue of Elements. For example, the toxic and and carcinogenic potential of mineral dusts inhaled into the lungs is related in part to biochemical reaction mechanisms involving iron and reactive oxygen species that occur at the mineral surface (Fubini et al. 1987; Castranova et al. 1997; Huang et al. 2006; Schoonen et al. 2006; Fubini and Fenoglio 2007 this issue) . Neurodegenerative disorders such as Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) and Alzheimer's disease (AD) may involve misfolding of specific proteins and in some cases, are specific to certain geographical locations such as Guam, West New Guinea, and the Kii Peninsula of Japan (Gadjusek 1963; Garruto and Yase 1986; Perl and Moalem 2006 ). An MMG approach and geochemistry could also help address the etiology, pathogenesis, geospatial foci, and potential genetic-environmental interactions involved.
Prions are a type of misfolded proteins that are the agents of transmissible spongiform encephalopathies (TSE) such as Creutzfeldt-Jakob disease and kuru in humans, "mad cow disease" or bovine spongiform encephalopathy, chronic wasting disease in elk, deer, and moose, and scrapie in sheep (Prusiner 1982) . The fate of prions, viruses, and other proteins in the geological environment provides a fascinating, growing area of research (Bales et al. 1991 (Bales et al. , 1993 Ragnarsdottir and Charlet 2002; Schramm et al. 2006; Quiquampoix and Burns 2007 this issue).
The formation of bones, teeth, otoconia (calcite crystals in the inner ear for sensing gravity and acceleration), kidney stones, gout and gall stones, as well as the "calcification" of vasculature (Glimcher 2006; Boskey 2007 this issue; Wesson and Ward 2007 this issue) present cases of normal and pathological biomineralization. A combined approach involving modern genetic, biochemical, spectroscopic, and microscopic methods of analysis, along with molecular modeling of proteins, peptides, and phospholipids would yield insight into the controlling mechanisms. The challenge in modeling reactions involving large mineral surfaces with biomolecules and water is the development of methods that are computationally affordable yet accurate, especially for interfacial reactions (Harding and Duffy 2006) . Related to bone and teeth mineralization is the area of biomaterials synthesis for orthopaedic and dental implants. The reactivity of oxide and silicate ceramic and composite biomaterials depends, in part, on the composition and structure of the ceramic, the rate at which it dissolves when implanted in the body, and the cellular response elicited by the ions leached from the bioceramic surface (Cerrutti and Sahai 2006; Jones et al. 2007 this issue). The reactions involved in the initial dissolution of the bioceramic are very similar to silicate weathering in the geochemical environment! Supported lipid bilayers (SLB), as suggested by their name, are synthetic phospholipid bilayers deposited on oxide surfaces and used as model cell-membranes (Cremer and Boxer 1999) . Proteins that can bind to proteins and other molecules present in solution may be embedded in the SLB. Thus, SLBs have potential applications as biosensors and in making biomaterials more biocompatible. The role of the oxide substrate in the stability and functioning of SLBs is only now beginning to be studied. With their extensive knowledge of oxide surface chemistry, geochemists could potentially contribute significantly to this field. As a final example, drugs and viable cells encapsulated within oxide nanoparticles have been proposed for drug delivery and cancer therapy. Understanding the synthesis, reactivity, and cytotoxic and carcinogenic potential of nanoparticles is well within the scope of MMG (Livage and Coradin 2006) .
SOLUTION CHEMISTRY: SPECIATION AND BIOORGANIC MOLECULES
An accurate consideration of equilibria and reaction pathways between minerals and dissolved species-as well as meaningful definitions of the terms bioavailability, bioaccessibility, biosolubility, and biopersistence for risk assessment of toxic and carcinogenic compounds-requires an accurate knowledge of aqueous speciation in the particular fluid. Excellent examples are provided in reviews of biological Al speciation (Martin 1991; Harris 1996; Stone 1997) . Solutions in different physiological environments vary in terms of pH, ionic strength, and dissolved inorganic ionic concentrations, and the pH of some fluids even changes with conditions. Thus, gastric fluid varies between pH ~1.5 and 6.5 in the absence and presence of food; sweat pH ranges from ~4 to 6.5; salivary pH changes from ~6.5 to 8 as flow conditions change from low to high; interstitial (between cells) blood plasma and extracellular lung fluid have pH ~7.5, but extracellular lung fluid is slightly more acidic at pH ~7; and macrophage lysosome has a low pH (~4.5) (Plumlee et al. 2006) . To cite other examples, Na + , K + , and Clconcentrations maintain osmotic balance across the cell membrane; in some cells Ca 2+ ions control the opening of cell-membrane channels, regulating traffic across the membrane; and trace elements such as Cu, Zn, and Mn are usually involved in specific protein functions. Redox conditions also vary in different physiological environments, from an oxygen partial pressure (pO 2 ) of 0.132 atm in arterial blood to 0.02-0.05 atm in venous blood (Plumlee et al. 2006) , and extremely toxic, reactive oxygen species are generated inside immune system cells called leukocytes in order to destroy pathogens such as bacteria, viruses, and inhaled dust particles.
While the inorganic speciation is relatively well known in many cases, it is difficult to obtain information on the myriad types of biological organic molecules and their concentrations, which may also vary with time and conditions (e.g. the rate of physical exertion, time since eating, health status, and age of the individual). These bioorganic molecules can form complexes with ions, function in redox reactions, and adsorb at mineral surfaces, thus affecting solution speciation as well as mineral surface reactivity, but their concentrations in fluids are difficult to determine. One of the challenges in studying biomedical processes from an inorganic physical chemistry perspective is the existence of such gaps in our knowledge.
SIZE, HIERARCHICAL ARRANGEMENT, AND TEMPORAL VARIATIONS
In addition to variations with time and conditions, bioorganic molecules vary in size from angstroms (0.1 nanometer or 1 x 10 -10 m) to nanometers. Accordingly, the principles of solution chemistry, colloid and surface chemistry, and bulk materials chemistry will need to be applied. Further, bioorganic molecules are arranged at varying levels of organization, from dissolved enzymes, vitamins, "co-factors" and other proteins to colloid-sized polysaccharides, phospholipids, antigens, etc. associated with cell surfaces, and amino acids, nucleic acids, RNA, DNA etc. in cell organelles. For example, a single molecule of aspartic acid is ~5Å long; dipalmitoylphosphocholine, a typical cell membrane-forming phospholipid, is ~3 nm in length; the infectious portion of a prion protein is estimated at ~10-30 nm; the core of apoferritin protein, within which ferrihydrite is located, has a diameter of ~ 6 nm, and the apoferritin cage itself is ~12 nm across.
The mineral phases associated with biomedical processes also range in size and in hierarchical arrangement. For instance, the calcium phosphate phase associated with mature bone is a non-stoichiometric, Ca-deficient, carbon-ate-enriched hydroxylapatite and occurs as plate-shaped nano-sized crystals 30-45 nm long and wide and ~2-3 nm thick. The crystals are arranged with their c-axes parallel to the long axis of collagen fibrils, and the fibrils themselves have a very particular three-dimensional arrangement. This specific, hierarchical arrangement of the organic collagen matrix and the inorganic calcium phosphate crystals gives bone its fabric and mechanical properties, while the small surface area of the crystals imparts to them a high surface reactivity, which is required for a mineral that acts as a reservoir of calcium (Glimcher 2006) . Moreover, unlike many other biominerals, bone is resorbed and continually "turned over." Osteoporosis occurs when the rate of resorption is greater than the rate of bone formation. Thus, the composition, size and, possibly, even the precursor calcium phosphate phase associated with bone vary with the age of the bone and the age of the individual. In other words, changes occur over space and time, so it is critical to understand that variations in the volume of tissue analyzed relative to the spatial resolution of the spectroscopic or microscopic analytical method could yield very different results (Glimcher 2006) .
In teeth, nanocrystals of apatite associated with collagen are found in the dentin, but enamel contains much larger (micron-sized) and better-organized apatite crystals (fewer substitutions, vacancies, and other defects), which are associated with the protein amelogenin. Moreover, teeth are not normally resorbed (excluding pathological formation of caries or tooth decay), suggesting different mechanisms of growth compared to bone. It would, therefore, be simplistic to state that our bones and teeth are composed of hydroxylapatite. It is crucial to recognize this complexity of biominerals when trying to understand the reaction equilibria and mechanisms involved in controlling their formation (and destruction, in the case of bone).
REACTION KINETICS
The interactions of minerals with dissolved inorganic and organic species occur dynamically, so it is important to consider reaction rates and pathways. For instance, silicate bioceramics of specific chemical compositions dissolve when implanted in bone in the body, with leaching of Ca 2+ and silicic acid from the implant and subsequent deposition of a new layer of hydroxylapatite at the implant surface. This apatite layer provides a stronger bone-implant bond and faster postsurgery recovery times. In this scenario, the rate at which blood plasma flows past a silicate bioceramic orthopaedic implant may control the silicate dissolution rate and the deposition rate of the hydroxylapatite layer, thus affecting the quality of the bone-implant bond, the postsurgical recovery time and the lifetime of the implant in the patient. Poiseuille studied blood flow in capillaries and veins as early as 1815, so one might imagine that the rate of blood flow should be well known by now. It may, therefore, be surprising to learn that this parameter is actually very poorly known because of physiological and practical complexities. Blood flow rates vary from one organ or tissue to another, with different types and levels of activity, and with the age and health of the individual. Moreover, the practical difficulties in measuring flow rates are obvious. In such situations, fluid mechanics models, including models for flow through porous media, may shed some much-needed light (Kufahl and Saha 1990; Dillaman et al. 1991; Hillsley and Frangos 1994) .
Reaction rates controlled by mineral surfaces are also critical, as exemplified by the effect of surface radicals on dust particles generated by freshly blasted rocks in mining, blasting and construction activities or radicals created in the mineral due to the presence of ferrous iron or other impurities, as in the case of anthracitic coal. The interaction of soluble, acidic proteins with dissolved ions and with mineral surfaces also controls the nucleation and growth of biominerals, such as apatite in bone and teeth, calcite otoconia in the inner ear, and the pathological mineralization of calcium oxalate as kidney stones and of uric acid crystals in the joints in gout.
ESTIMATION OF SURFACE AREA
Although the importance of reactive surface area of minerals is appreciated, the specific surface is operationally determined by a N 2 or Ar gas adsorption isotherm such as the Brunauer-Emmett-Teller (BET) isotherm. Even this value, however, may not accurately represent the actual surface area involved in the reaction. For instance, the size of inhaled particles is an important factor in controlling whether they are cleared from the respiratory tract or whether they accumulate in the lungs, where they may cause respiratory disorders and even cancer over long periods of exposure. The aggregation of smaller particles into larger ones may reduce the effective surface area accessible to larger biomolecules, while smaller inorganic ions such as H + or metal ions may access the entire surface area represented by the BET value. The amount of adsorbed biomolecule per unit surface area will then appear to be anomalously low. Similar considerations apply to nanoparticles encapsulating drugs or viable cells that have potential for use as targeted drug delivery agents in the treatment of cancer and other diseases.
THE TOOL KIT
From the preceding discussion, it is apparent that the medical mineralogist or geochemist must use an impressive array of tools in order to analyze, characterize, and study inorganic species, bioorganic molecules, and minerals in aqueous solutions across a variety of spatial and temporal scales in controlled laboratory experiments; it is even more challenging to make measurements in vivo. Geochemists and mineralogists are already skilled in dealing with similar complexities in the geological environment and in the use of advanced spectroscopic, microscopic, and solution analysis methods, as well as quantum and classical approaches to model reactions at the molecular scale. Collaboration with researchers in the chemical, biological, and biomedical fields is also almost inevitable in order to carry out the complementary and absolutely necessary genetic, cellular, and biomolecular studies.
THE MENTAL CHALLENGE
There are many intellectual challenges in the MMG field, and I have attempted to address some of them above. I distinguish these from "mental challenges," by which I mean the effort required to establish such interdisciplinary collaborations, find the appropriate research funding, and deal with journal editors and reviewers who resist publishing the results of such work. In short, educational outreach must be targeted not only at the general public but also at our own community of geoscientists and at the larger community of chemists, biologists, and biomedical researchers. The task is difficult but not impossible, as evidenced by the existing collaborations among biomedical researchers, clinical medical practitioners, and certain geochemistry and mineralogy groups in the United States and internationally; by the financial support provided by specific programs within NSF, DOE, and the USGS towards a medical mineralogy and geochemistry short course in December 2006; and by the growing number of books and conference symposia in the subject area.
